Shilts, Meghan H.
Rosas-Salazar, Christian
Lynch, Christian E.
Tovchigrechko, Andrey
Boone, Helen H.
Russell, Patty B.
Connolly, Alexandra S.
Costello, Kaitlin M.
McCollum, Megan D.
Mai, Annie
Wiggins, Derek A.
Rajagopala, Seesandra V.
Yooseph, Shibu
Peebles, R. Stokes
Hartert, Tina V.
Das, Suman R.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K24AI77930, HHSN272200900007C)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD087023)
Parker B. Francis Fellowship Program
NIAID, NIH (U19AI095227)
National Institute of Diabetes and Digestive and Kidney Diseases (U2CDK059637)
NIDDK (P30DK020593)
Article History
Received: 10 January 2020
Accepted: 3 November 2020
First Online: 26 November 2020
Competing interests
: AT works at and owns stocks from AstraZeneca. The other authors declare no competing interests.